Screener / SEC EDGAR /CIK 0002046386 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Instruments

Medline Inc. MDLN

Compare with peers Embed

MDLN among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
+11.5%73rd of 155 · median +10.5%
Net margin
-4.1%15.3%
4.1%85th of 154 · median 6.8%
Return on equity
-5.2%18.5%
9.8%69th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
6.2%90th of 145 · median 10.0%
Debt / equity (less is better)
1.160.42
1.0777th of 108 · median 0.69

MDLN and 9 peers, year by year

The 9 Health care companies closest to MDLN in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
MDLN Medline Inc. FY2025 $28.4B+11.5%26.4%7.8%4.1%4.6%10.8%1.17
GILD Gilead Sciences FY2025 $29.4B+2.4%-34.0%28.9%32.1%37.5%1.10
SYK Stryker Corporation FY2025 $25.1B+11.2%64.0%19.5%12.9%17.1%14.5%0.66
DHR Danaher Corporation FY2025 $24.6B+2.9%59.1%19.1%14.7%21.4%6.9%0.35
MDT Medtronic FY2026 $36.4B+8.4%-17.8%13.2%14.9%9.7%0.57
BDX Becton Dickinson FY2025 $21.8B+8.2%-11.8%7.7%12.2%6.6%0.76
AMGN Amgen FY2025 $36.8B+10.0%-24.7%21.0%22.0%89.1%6.31
THC Tenet Healthcare Corp FY2025 $21.3B+3.1%-16.5%6.6%11.9%33.3%3.12
GEHC GE HealthCare FY2025 $20.6B+4.8%40.0%13.4%10.1%7.3%20.1%1.01
BSX Boston Scientific FY2025 $20.1B+19.9%69.0%18.0%14.4%18.2%12.0%0.47

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2023 to FY2025 · 10-K XBRL

MDLNMedline Inc.
FY2023 revenue $23.2BFY2024 revenue $25.5BFY2025 revenue $28.4B FY2023 net margin 1.0%FY2024 net margin 4.6%FY2025 net margin 4.1% FY2023FY2025
Revenue$28.4B Growth+11.5% Net margin4.1%
GILDGilead Sciences
FY2023 revenue $27.1BFY2024 revenue $28.8BFY2025 revenue $29.4B FY2023 net margin 20.9%FY2024 net margin 1.7%FY2025 net margin 28.9% FY2023FY2025
Revenue$29.4B Growth+2.4% Net margin28.9%
SYKStryker Corporation
FY2023 revenue $20.5BFY2024 revenue $22.6BFY2025 revenue $25.1B FY2023 net margin 15.4%FY2024 net margin 13.2%FY2025 net margin 12.9% FY2023FY2025
Revenue$25.1B Growth+11.2% Net margin12.9%
DHRDanaher Corporation
FY2023 revenue $23.9BFY2024 revenue $23.9BFY2025 revenue $24.6B FY2023 net margin 19.9%FY2024 net margin 16.3%FY2025 net margin 14.7% FY2023FY2025
Revenue$24.6B Growth+2.9% Net margin14.7%
MDTMedtronic
FY2023 revenue $31.2BFY2024 revenue $32.4BFY2025 revenue $33.5B FY2023 net margin 12.0%FY2024 net margin 11.4%FY2025 net margin 13.9% FY2023FY2025
Revenue$33.5B Growth+3.6% Net margin13.9%
BDXBecton Dickinson
FY2023 revenue $19.4BFY2024 revenue $20.2BFY2025 revenue $21.8B FY2023 net margin 7.7%FY2024 net margin 8.4%FY2025 net margin 7.7% FY2023FY2025
Revenue$21.8B Growth+8.2% Net margin7.7%
AMGNAmgen
FY2023 revenue $28.2BFY2024 revenue $33.4BFY2025 revenue $36.8B FY2023 net margin 23.8%FY2024 net margin 12.2%FY2025 net margin 21.0% FY2023FY2025
Revenue$36.8B Growth+10.0% Net margin21.0%
THCTenet Healthcare Corp
FY2023 revenue $20.6BFY2024 revenue $20.7BFY2025 revenue $21.3B FY2023 net margin 3.0%FY2024 net margin 15.5%FY2025 net margin 6.6% FY2023FY2025
Revenue$21.3B Growth+3.1% Net margin6.6%
GEHCGE HealthCare
FY2023 revenue $19.6BFY2024 revenue $19.7BFY2025 revenue $20.6B FY2023 net margin 8.0%FY2024 net margin 10.1%FY2025 net margin 10.1% FY2023FY2025
Revenue$20.6B Growth+4.8% Net margin10.1%
BSXBoston Scientific
FY2023 revenue $14.2BFY2024 revenue $16.7BFY2025 revenue $20.1B FY2023 net margin 11.0%FY2024 net margin 11.1%FY2025 net margin 14.4% FY2023FY2025
Revenue$20.1B Growth+19.9% Net margin14.4%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2023 to FY2025

Revenue as reported in the 10-K.

100 FY2023FY2024FY2025 GILD: $27.1B, $28.8B, $29.4B GILD SYK: $20.5B, $22.6B, $25.1B SYK DHR: $23.9B, $23.9B, $24.6B DHR MDT: $31.2B, $32.4B, $33.5B MDT BDX: $19.4B, $20.2B, $21.8B BDX AMGN: $28.2B, $33.4B, $36.8B AMGN THC: $20.6B, $20.7B, $21.3B THC GEHC: $19.6B, $19.7B, $20.6B GEHC BSX: $14.2B, $16.7B, $20.1B BSX MDLN: $23.2B, $25.5B, $28.4B MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number.

Sales growth, FY2023 to FY2025

Revenue against the fiscal year before.

−10.3% +19.9% FY2023FY2024FY2025 GILD: −0.6%, +6.0%, +2.4% GILD SYK: +11.1%, +10.2%, +11.2% SYK DHR: −10.3%, −0.1%, +2.9% DHR MDT: −1.4%, +3.6%, +3.6% MDT BDX: +2.7%, +4.2%, +8.2% BDX AMGN: +7.1%, +18.6%, +10.0% AMGN THC: +7.2%, +0.5%, +3.1% THC GEHC: +6.6%, +0.6%, +4.8% GEHC BSX: +12.3%, +17.6%, +19.9% BSX MDLN: -, +9.8%, +11.5% MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −10.3% to +19.9%. A gap is a year with no number. A ring marks where a line starts: MDLN has no earlier 10-K here.

Gross margin, FY2023 to FY2025

Gross profit / revenue.

25.3% 69.5% FY2023FY2024FY2025 SYK: 63.7%, 63.9%, 64.0% SYK DHR: 58.7%, 59.5%, 59.1% DHR GEHC: 40.5%, 41.7%, 40.0% GEHC BSX: 69.5%, 68.6%, 69.0% BSX MDLN: 25.3%, 27.3%, 26.4% MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 25.3% to 69.5%. A gap is a year with no number.
CompanyFY2023FY2024FY2025
MDLN Dec 25.3%27.3%26.4%
GILD Dec ---
SYK Dec 63.7%63.9%64.0%
DHR Dec 58.7%59.5%59.1%
MDT Apr ---
BDX Sep ---
AMGN Dec ---
THC Dec ---
GEHC Dec 40.5%41.7%40.0%
BSX Dec 69.5%68.6%69.0%
Peer median61.2%61.7%61.5%

Operating margin, FY2023 to FY2025

Operating income / revenue.

5.4% 34.0% FY2023FY2024FY2025 GILD: 28.0%, 5.8%, 34.0% GILD SYK: 19.0%, 16.3%, 19.5% SYK DHR: 21.8%, 20.4%, 19.1% DHR MDT: 17.6%, 15.9%, 17.8% MDT BDX: 10.9%, 11.9%, 11.8% BDX AMGN: 28.0%, 21.7%, 24.7% AMGN THC: 12.2%, 28.8%, 16.5% THC GEHC: 12.5%, 13.3%, 13.4% GEHC BSX: 16.5%, 15.5%, 18.0% BSX MDLN: 5.4%, 8.4%, 7.8% MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 5.4% to 34.0%. A gap is a year with no number.

Net margin, FY2023 to FY2025

Net income / revenue.

1.0% 28.9% FY2023FY2024FY2025 GILD: 20.9%, 1.7%, 28.9% GILD SYK: 15.4%, 13.2%, 12.9% SYK DHR: 19.9%, 16.3%, 14.7% DHR MDT: 12.0%, 11.4%, 13.9% MDT BDX: 7.7%, 8.4%, 7.7% BDX AMGN: 23.8%, 12.2%, 21.0% AMGN THC: 3.0%, 15.5%, 6.6% THC GEHC: 8.0%, 10.1%, 10.1% GEHC BSX: 11.0%, 11.1%, 14.4% BSX MDLN: 1.0%, 4.6%, 4.1% MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 1.0% to 28.9%. A gap is a year with no number.

Free cash flow, FY2023 to FY2025

Cash from operations minus capital spending.

100 200 FY2023FY2024FY2025 GILD: $7.4B, $10.3B, $9.5B GILD SYK: $3.1B, $3.5B, $4.3B SYK DHR: $5.8B, $5.3B, $5.3B DHR MDT: $4.6B, $5.2B, $5.2B MDT BDX: $2.1B, $3.1B, $2.7B BDX AMGN: $7.4B, $10.4B, $8.1B AMGN THC: $1.6B, $1.1B, $2.5B THC GEHC: $1.7B, $1.6B, $1.5B GEHC BSX: $1.8B, $2.6B, $3.7B BSX MDLN: $1.4B, $1.4B, $1.3B MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number.

FCF margin, FY2023 to FY2025

Free cash flow / revenue.

4.6% 35.8% FY2023FY2024FY2025 GILD: 27.4%, 35.8%, 32.1% GILD SYK: 15.3%, 15.4%, 17.1% SYK DHR: 24.2%, 22.2%, 21.4% DHR MDT: 14.7%, 16.1%, 15.5% MDT BDX: 10.9%, 15.5%, 12.2% BDX AMGN: 26.1%, 31.1%, 22.0% AMGN THC: 7.9%, 5.4%, 11.9% THC GEHC: 8.8%, 7.9%, 7.3% GEHC BSX: 12.6%, 15.8%, 18.2% BSX MDLN: 6.1%, 5.5%, 4.6% MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 4.6% to 35.8%. A gap is a year with no number.

Return on equity, FY2023 to FY2025

Net income / shareholders' equity at the year end.

2.5% 107.8% FY2023FY2024FY2025 GILD: 24.8%, 2.5%, 37.5% GILD SYK: 17.0%, 14.5%, 14.5% SYK DHR: 8.9%, 7.9%, 6.9% DHR MDT: 7.3%, 7.3%, 9.7% MDT BDX: 5.8%, 6.6%, 6.6% BDX AMGN: 107.8%, 69.6%, 89.1% AMGN THC: 38.0%, 76.7%, 33.3% THC GEHC: 22.0%, 23.6%, 20.1% GEHC BSX: 8.1%, 8.5%, 12.0% BSX MDLN: -, -, 10.8% MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 2.5% to 107.8%. A gap is a year with no number. A ring marks where a line starts: MDLN has no earlier 10-K here.
CompanyFY2023FY2024FY2025
MDLN Dec --10.8%
GILD Dec 24.8%2.5%37.5%
SYK Dec 17.0%14.5%14.5%
DHR Dec 8.9%7.9%6.9%
MDT Apr 7.3%7.3%9.7%
BDX Sep 5.8%6.6%6.6%
AMGN Dec 107.8%69.6%89.1%
THC Dec 38.0%76.7%33.3%
GEHC Dec 22.0%23.6%20.1%
BSX Dec 8.1%8.5%12.0%
Peer median17.0%8.5%14.5%

Debt / equity, FY2023 to FY2025

Total debt / shareholders' equity at the year end.

0.33 10.37 FY2023FY2024FY2025 GILD: 1.09, 1.38, 1.10 GILD SYK: 0.59, 0.59, 0.66 SYK DHR: 0.38, 0.33, 0.35 DHR MDT: 0.47, 0.50, 0.53 MDT BDX: 0.62, 0.78, 0.76 BDX AMGN: 10.37, 10.23, 6.31 AMGN THC: 9.33, 3.16, 3.12 THC GEHC: 1.46, 1.24, 1.01 GEHC BSX: 0.47, 0.49, 0.47 BSX MDLN: -, -, 1.17 MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.33 to 10.37. A gap is a year with no number. A ring marks where a line starts: MDLN has no earlier 10-K here.
CompanyFY2023FY2024FY2025
MDLN Dec --1.17
GILD Dec 1.091.381.10
SYK Dec 0.590.590.66
DHR Dec 0.380.330.35
MDT Apr 0.470.500.53
BDX Sep 0.620.780.76
AMGN Dec 10.3710.236.31
THC Dec 9.333.163.12
GEHC Dec 1.461.241.01
BSX Dec 0.470.490.47
Peer median0.620.780.76

EPS (diluted), FY2023 to FY2025

Diluted earnings per share, on today's share count after splits.

−$0.01 $32.70 FY2023FY2024FY2025 GILD: $4.50, $0.38, $6.78 GILD SYK: $8.25, $7.76, $8.40 SYK DHR: $6.38, $5.29, $5.05 DHR MDT: $2.82, $2.76, $3.61 MDT BDX: $4.94, $5.86, $5.82 BDX AMGN: $12.49, $7.56, $14.23 AMGN THC: $5.71, $32.70, $15.49 THC GEHC: $3.03, $4.34, $4.55 GEHC BSX: $1.07, $1.25, $1.94 BSX MDLN: -, -, −$0.01 MDLN
MDLN is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$0.01 to $32.70. A gap is a year with no number. A ring marks where a line starts: MDLN has no earlier 10-K here.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out MDLN and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: MDLN's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MDLN/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.